GlassScriptPhysician profile
Tamika Scott
NPI 1699314393
$4,107.32
in general payments reported to CMS, 2019-2025
30 companies · $376 in 2025
The $376 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,215 · 2022: $659 · 2023: $963 · 2024: $896 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,233.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $2,030.79 | 2021-2025 | Belbuca, Xtampza |
| Protega Pharmaceutials INC | $283.77 | 2023-2025 | Roxybond |
| Almatica Pharma LLC | $281.59 | 2021-2022 | |
| Nevro Corp. | $167.44 | 2021-2024 | Senza |
| Grt US Holding, INC. | $156.58 | 2021-2022 | |
| Electronic Waveform Lab, INC. | $133.27 | 2023-2024 | |
| Biodelivery Sciences International, INC. | $124.79 | 2021 | |
| Redhill Biopharma INC. | $91.20 | 2021 | |
| Eisai INC. | $79.73 | 2021 | |
| Averitas Pharma INC. | $76.46 | 2023-2024 | Qutenza |
| Scilex Pharmaceuticals INC. | $75.61 | 2021-2024 | Ztlido |
| Boston Scientific Corporation | $73.29 | 2022-2023 | Wavewriter Alpha Prime 16 |
| Ibsa Pharma INC. | $59.32 | 2021-2024 | Licart, Tirosint |
| Medtronic, INC. | $51.85 | 2021-2025 | Accurian, Kyphon Express II Kyphopak Tray |
| Fidia Pharma USA INC. | $48.65 | 2021-2024 | Triluron, Hymovis, Hyalgan |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $48.21 | 2022-2025 | Ha Minuteman G3-R |
| Depuy Synthes Sales INC. | $46.78 | 2021 | |
| Pfizer INC. | $34.22 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $29.13 | 2024 | Kristalose |
| Idorsia Pharmaceuticals US INC | $24.92 | 2023 | Quviviq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.23 | 2021-2023 | Relistor |
| Stimwave Technologies Incorporated | $24.08 | 2021-2022 | |
| Si-Bone, INC. | $23.09 | 2023 | |
| Abbvie INC. | $22.45 | 2025 | |
| Mallinckrodt Hospital Products INC. | $20.49 | 2024 | Acthar |
| Virtus Pharmaceuticals LLC | $16.75 | 2021 | |
| Convatec INC. | $16.69 | 2024 | |
| Hikma Pharmaceuticals USA | $16.66 | 2023 | Kloxxado |
| Vertos Medical, INC. | $13.62 | 2024 | Mild Device Kit |
| Horizon Therapeutics Plc | $11.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamika Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.